Chronic renal failure. End stage kidney disease:on dialysis
Conditions
Interventions
Intervention/Control 1
CONTROL: temperature of hemodialysis fluid (dialysate) is regulated on 37 ° C . Type of filter, coefficient of ultra-filtration, blood flow rate and type of apparatus are consta
Intervention/Control 1
CONTROL: temperature of hemodialysis fluid (dialysate) is regulated on 37 ° C . Type of filter, coefficient of ultra-filtration, blood flow rate and type of apparatus are const
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: consent for participation in the study; Age older than 18 years and maximum 75 years; suffering from vision, hearing loss; not suffering from clear mental disorders and severe emotional mood disorders, which prevent effective communication; Patients with chronic renal failure (patients who 6 months have passed since their dialysis); Patients receiving dialysis treatment three times a week and each session for 4 hours; not suffering from endocrine disorders (such as hypothyroidism, hyperparathyroidism; Patients who have received score higher than 5 Pittsburgh Sleep Quality Index; Patients with hemoglobin levels are greater than 8 mg dl; Lack of debilitating diseases and disorders such as severe chronic heart, respiratory, hepatic, history of seizures and severe neuropathy based on medical records and patient history; Lack of psychiatric disorders (schizophrenia, anxiety, depression) or dementia Or stay in psychiatric wards because of the items listed; No history of kidney transplant; Exclusion criteria: Patients who develop acute complications during hemodialysis (Disequilibrium syndrome - embolism - dysrhythmia – cardiac, respiratory arrest - Coma -); patients who discontinued they dialysis for any reason; Patients who are referred for kidney transplants (Patients who get kidney transplantation during the study); the patient's death, patients who cannot tolerate cold dialysis; the patient's unwillingness to continue to participate in the study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Sleep quality. Timepoint: Before, during and after intervention. Method of measurement: Pittsburgh Sleep Quality Index. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRoghayyeh ghanbarabadi
Sabzevar University of Medical Sciences
Outcome results
None listed